The discovery of vanadyl and zinc complexes for treating diabetes and metabolic syndromes
Authors:
- 1 June 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 2 (6) , 873-887
Abstract
The incidence of diabetes mellitus has increased over the decades because of lifestyle changes. The number of people with diabetes mellitus worldwide is expected to increase from 150 million to 220 million by 2010 and to 300 million by 2025. There are two main types of diabetes mellitus. Type 1 diabetes mellitus is due to the autoimmune-mediated destruction of pancreatic β cells, resulting in absolute insulin deficiency; the patients require exogenous insulin injections. Type 2 is characterized by insulin resistance and abnormal insulin secretion and the patients require exercise, diet control and/or oral hypoglycemics. However, each treatment has some adverse effects, including physical burden, formation of self-antibodies for insulin injections, the severe side effects of hypoglycemics and the discontinuation of insulin synthesis in the pancreas. To overcome these adverse effects and replace the use of these agents, the author attempted to develop new antidiabetic agents with novel structures and mechanisms. This review focuses on the authors' recent development of vanadium and zinc complexes for antidiabetic and antimetabolic syndromes.Keywords
This publication has 92 references indexed in Scilit:
- A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complexLife Sciences, 2007
- Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmonyJournal of Clinical Investigation, 2006
- Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complexBiochemical and Biophysical Research Communications, 2006
- Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytesLife Sciences, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006
- The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytesLife Sciences, 2004
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Orally Active and Long-Term Acting Insulin-Mimetic Vanadyl Complex: Bis(Picolinato)oxovanadium(IV)Biochemical and Biophysical Research Communications, 1995
- Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptorBiochemical and Biophysical Research Communications, 1983
- Effects of vanadium on glucose metabolismLife Sciences, 1979